Acetazolamide As A Valuable Addition to Acute Heart Failure?

References

1. 1.↵
   1. Mullens W,
   2. Dauw J,
   3. Martens P,
   4. et al

   . Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics. Eur J Heart Fail 2022;24:1601–10.

   OpenUrl
2. 2.↵
   1. Abraham WT,
   2. Fonarow GC,
   3. Albert NM

   , OPTIMIZE-HF Investigators and Coordinatorset al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347–56.

   OpenUrlFREE Full Text
3. 3.↵
   1. Go AS,
   2. Mozaffarian D,
   3. Roger VL

   , American Heart Association Statistics Committee and Stroke Statistics Subcommitteeet al. Heart disease and stroke statistics–2013 update: a report from the American Heart Association [published correction appears in Circulation. Circulation 2013;127:e6–e245. 2013 Jan 1;127(1): [published correction appears in Circulation. 2013 Jun 11;127(23):e841].

   OpenUrlFREE Full Text
4. 4.↵
   1. Arrigo M,
   2. Jessup M,
   3. Mullens W,
   4. et al

   . Acute heart failure. Nat Rev Dis Primers 2020;6:16. Published 2020 Mar 5.

   OpenUrl
5. 5.↵
   1. Gill GS,
   2. Lam PH,
   3. Brar V,
   4. et al

   . In-hospital weight loss and outcomes in patients with heart failure. J Card Fail 2022;28:1116–24.

   OpenUrl
6. 6.↵
   1. Adams KF Jr.,
   2. Fonarow GC,
   3. Emerman CL

   , ADHERE Scientific Advisory Committee and Investigatorset al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209–16.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   Writing Committee Members; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Card Fail 2022;28:e1–e167.

   OpenUrlCrossRef
8. 8.↵
   1. Cox ZL,
   2. Hung R,
   3. Lenihan DJ,
   4. Testani JM

   . Diuretic strategies for loop diuretic resistance in acute heart failure: The 3T trial. JACC Heart Fail 2020;8:157–68.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Côté JM,
   2. Bouchard J,
   3. Murray PT,
   4. Beaubien-Souligny W

   . Diuretic strategies in patients with resistance to loop-diuretics in the intensive care unit: a retrospective study from the MIMIC-III database. J Crit Care 2021;65:282–91.

   OpenUrl
10. 10.↵
    The Priority Updates from the Research Literature (PURLs) Methodology. Available at: https://journals.lww.com/ebp/Documents/PURLs%20Methods%20AC.pdf.